Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis–associated peritonitis
Sign Up to like & getrecommendations! Published in 2022 at "Peritoneal Dialysis International"
DOI: 10.1177/08968608211064192
Abstract: Background: The role of monitoring serum vancomycin levels during treatment of peritoneal dialysis (PD)–associated peritonitis is controversial. Substantial inter-individual variability may result in suboptimal serum levels despite similar dosing of vancomycin. The published predictors of… read more here.
Keywords: vancomycin; term adverse; adverse outcomes; serum vancomycin ... See more keywords